Richard Stratford

Richard Stratford is a seasoned professional in the life sciences sector, currently serving as Co-founder and Advisor at NEC OncoImmunity AS since August 2019, and previously holding the position of Chief Executive Officer at OncoImmunity AS from January 2014 to July 2019. Richard has extensive experience in business development, having worked as an Independent business development consultant at Singleøen Mekaniske Verksted AS from January 2010 to December 2013, where services included market analysis and IP management. Prior roles also include Head of Business Development at LingVitae and Business Development Manager positions at SingVax Pte Ltd and Microscience. Richard holds a PhD in Immunology and Molecular Biology from Imperial College London and a BSc in Biochemistry and related fields from Newcastle University.